Zacks Investment Research on MSN
Dexcom reports positive CONNECT data for non-insulin diabetes
DexCom, Inc. DXCM recently announced positive results from its CONNECT randomized controlled trial, demonstrating that use of ...
Dexcom reaffirms CGM benefits for all people with diabetes and continues momentum towards earlier stage intervention and ...
CGMs can help people avoid serious diabetes complications, save money through better management and adjust behavior based on ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results